Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neurocrine Biosciences Inc.

www.neurocrine.com

Latest From Neurocrine Biosciences Inc.

Teva’s Ajovy Claims 28%-30% New Prescription Share In Competitive CGRP Race

The company said it has captured a roughly 28%-30% share of new prescriptions in the CGRP market with the initial launch of Ajovy, a key future growth driver to offset declining Copaxone sales.

Sales & Earnings Launches

Why Biogen/Eisai's Aducanumab Failure Is Not The End Of Amyloid Hypothesis

Biogen and Eisai still have multiple programs testing amyloid-targeting therapies in the treatment of Alzheimer's disease, but pressure for Biogen to focus its efforts elsewhere are mounting after the partners discontinued Phase III studies for aducanumab.

Clinical Trials Neurology

Neurocrine Shines In Congenital Adrenal Hyperplasia, But Competitor Is Close

Spruce's competing drug with same mechanism of action is also in Phase II, with data expected at the end of March.

Clinical Trials Research & Development

Start-Up Spruce Repurposes Lilly Drug For Genetic Adrenal Condition

Emerging Company Profile: Spruce and Neurocrine are both testing CRF-R1 antagonists for the orphan disease congenital adrenal hyperplasia, with Phase II data coming soon.

StartUps and SMEs Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Gynecological, Urological
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Neurocrine Biosciences Inc.
  • Senior Management
  • Kevin C Gorman, PhD, CEO
    Kyle Gano, PhD, Chief Bus. Dev. Officer
    Haig Bozigian, PhD, Chief Dev. Officer
    Dimitri Grigoriadis, PhD, Chief Research Officer
    Malcolm Lloyd-Smith , Chief Reg. Officer
    Christopher O'Brien, MD, CMO
  • Contact Info
  • Neurocrine Biosciences Inc.
    Phone: (858) 617-7600
    12780 El Camino Real
    San Diego, CA 92130
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register